Effect of antidepressant drugs on the human corticotropin-releasing- hormone gene promoter activity in neuro-2A cells

Polish Journal of Pharmacology

Volumn 54, Issue 6, 2002, Pages 711-716

  Budziszewska, Bogusława ^a   Jaworska Feil, Lucylla ^a   Tetich, Magdalena ^a   Basta Kaim, Agneiszka ^a   Kubera, Marta ^a   Leśkiewicz, Monika ^a   Lasoń, Władysław ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Corticotropin releasing hormone; Fluoxetine; Gene promoter activity; Imipramine; Neuro 2A cells; Tianeptine

Indexed keywords

ADENYLATE CYCLASE ACTIVATOR; ANTIDEPRESSANT AGENT; CHLORAMPHENICOL ACETYLTRANSFERASE; CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP; DRUG VEHICLE; FLUOXETINE; FORSKOLIN; IMIPRAMINE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C ACTIVATOR; TIANEPTINE;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; DNA RESPONSIVE ELEMENT; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; GENE ACTIVITY; GENE CONTROL; GENETIC TRANSFECTION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PLASMID; PROMOTER REGION; REPORTER GENE; TIME;

ANIMALS; ANTIDEPRESSIVE AGENTS; CELL SURVIVAL; CHLORAMPHENICOL O-ACETYLTRANSFERASE; CORTICOTROPIN-RELEASING HORMONE; CYCLIC AMP; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; NEUROBLASTOMA; PROMOTER REGIONS (GENETICS); TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0036965775     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Basta-Kaim A., Budziszewska B., Jaworska-Feil L., Tetich M., Leśkiewicz M., Kubera M., Lasoń W.: Chlorpromazine inhibits the glucocorticoid receptor-mediated gene transcription in a calcium-dependent manner. Neuropharmacology, 2002, 43, 1035-1043.
2. Brady L.S, Gold P.W., Herkenham M., Lynn A.B., Whitfield H.J.: The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications. Brain Res., 1992, 572, 117-125.
3. Budziszewska B., Jaworska-Feil L., Kajta M., Lasoń W.: Antidepressant drugs inhibit glucocorticoid receptor-mediated gene transcription - a possible mechanism. Brit. J. Pharmacol., 2000, 130, 1385-1393.
4. Chatterjee D., Chakraborty M., Anderson G.M.: Differentiation of Neuro-2a neuroblastoma cells by an antibody to GM3 ganglioside. Brain Res., 1992, 583, 31-44.
5. Dabrowski S., Kur J.: Cloning and expression in Escherichia coli of the recombinant his-tagged DNA polymerases from Pyrococcus furiosus and Pyrococcus woesei. Protein Express. Purif., 1998, 14, 131-138.
6. Delbende C., Contesse V., Mocaer E., Kamoun A., Vaudry H.: The novel antidepressant, tianeptine, reduces stress-evoked stimulation of the hypothalamo-pituitary-adrenal axis. Eur. J. Pharmacol., 1991, 24, 391-396.
7. Guardiola-Diaz H.M., Boswell C., Seasholtz A.F.: The cAMP-responsive element in the corticotropin-releasing hormone gene mediates transcriptional regulation by depolarization. J. Biol. Chem., 1994, 269, 14784-14791.
8. Holsboer F., Barden N.: Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocrine Rev., 1996, 17, 187-205.
9. Itoi K., Horiba N., Tozawa, F., Sakai Y., Sakai K., Abe K., Demura H., Suda T.: Major role of 3′5′-cyclic adenosine monophosphate-dependent protein kinase A pathway in corticotropin-releasing factor gene expression in the rat hypothalamus in vivo. Endocrinology, 1996, 137, 2389-2396.
10. Klebe R.J., Ruddle F.H.: Neuroblastoma: cell culture analysis of a differentiating stem cell system. J. Cell. Biol., 1969, 43, 69.
11. Pariante C.M., Miller A.H.: Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol. Psychiat., 2001, 49, 391-404.
12. Pariante C.M., Pearce B.D., Pisell T.L., Owens M.J., Miller A.H.: Steroid-independent translocation of the glucocorticoid receptor by the antidepressant desipramine. Mol. Pharmacol., 1997, 52, 571-581.
13. Pepin M.-C., Govindan M.V, Barden N.: Increased glucocorticoid receptor gene promoter activity after antidepressant treatment. Mol. Pharmacol., 1992, 41, 1016-1022.
14. Schwaninger M., Schofl C., Blume R., Rossig L., Knepel W.: Inhibition by antidepressant drugs of cyclic AMP response element-binding protein/cyclic AMP response element-directed gene transcription. Mol. Pharmacol., 1995, 47, 1112-1118.
15. Stout S.C., Owens M.J., Nemeroff C.B.: Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatment. J. Pharmacol. Exp. Ther., 2002, 300, 1085-1092.
16. Vamvakopoulos N.C., Chrousos G.P: Hormonal regulation of human corticotropin-releasing hormone gene expression: implications for the stress response and immune/inflammatory reaction. Endocrine. Rev. 1994, 15, 409-420.